Global Home Pet Deworming Medicine Market Growth 2024-2030
The global Home Pet Deworming Medicine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Home Pet Deworming Medicine Industry Forecast” looks at past sales and reviews total world Home Pet Deworming Medicine sales in 2023, providing a comprehensive analysis by region and market sector of projected Home Pet Deworming Medicine sales for 2024 through 2030. With Home Pet Deworming Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Home Pet Deworming Medicine industry.
This Insight Report provides a comprehensive analysis of the global Home Pet Deworming Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Home Pet Deworming Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Home Pet Deworming Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Home Pet Deworming Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Home Pet Deworming Medicine.
United States market for Home Pet Deworming Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Home Pet Deworming Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Home Pet Deworming Medicine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Home Pet Deworming Medicine players cover Zoetis, Merck & Co, Inc., Sava Healthcare Limited, Boehringer Ingelheim International GmbH, Ceva, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Home Pet Deworming Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Internal Deworming
External Deworming
Segmentation by Application:
Cats
Dogs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zoetis
Merck & Co, Inc.
Sava Healthcare Limited
Boehringer Ingelheim International GmbH
Ceva
Elanco
Virbac
PetIQ, LLC
Liquid Fence
Bird-X
HortiCentre
Green Gardener
The Big Cheese
Yorkshire Trading Company
Ramical
Beaphar
Agland
Key Questions Addressed in this Report
What is the 10-year outlook for the global Home Pet Deworming Medicine market?
What factors are driving Home Pet Deworming Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Home Pet Deworming Medicine market opportunities vary by end market size?
How does Home Pet Deworming Medicine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.